GoodRx Holdings, Inc.
GDRX
$2.61
-$0.08-2.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.19% | 0.57% | 1.30% | 3.20% | 4.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.19% | 0.57% | 1.30% | 3.20% | 4.35% |
| Cost of Revenue | 31.11% | 19.46% | 12.07% | -5.84% | -15.61% |
| Gross Profit | -3.31% | -0.65% | 0.62% | 3.87% | 6.00% |
| SG&A Expenses | -3.31% | -4.67% | -5.78% | -8.07% | -3.70% |
| Depreciation & Amortization | 15.56% | 22.55% | 71.42% | 22.97% | 20.23% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.68% | -0.36% | 3.27% | -3.93% | -2.02% |
| Operating Income | -13.32% | 7.05% | -9.76% | 87.14% | 80.39% |
| Income Before Tax | -4.86% | 79.71% | 1,272.64% | 194.05% | 181.25% |
| Income Tax Expenses | 28.73% | 73.19% | 89.08% | 3,524.92% | 137.07% |
| Earnings from Continuing Operations | -27.75% | 85.72% | 295.78% | 158.96% | 531.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.75% | 85.72% | 295.78% | 158.96% | 531.93% |
| EBIT | -13.32% | 7.05% | -9.76% | 87.14% | 80.39% |
| EBITDA | 7.96% | 25.12% | -0.55% | 33.76% | 28.75% |
| EPS Basic | -22.00% | 94.46% | 322.80% | 165.59% | 533.53% |
| Normalized Basic EPS | -12.13% | 20.93% | -4.76% | 151.92% | 128.68% |
| EPS Diluted | -21.58% | 96.27% | 320.51% | 165.31% | 474.87% |
| Normalized Diluted EPS | -11.49% | 21.96% | -4.35% | 152.67% | 127.24% |
| Average Basic Shares Outstanding | -8.74% | -6.86% | -5.49% | -5.43% | -6.31% |
| Average Diluted Shares Outstanding | -9.72% | -7.85% | -6.28% | -5.19% | -5.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |